深圳普门科技股份有限公司的主营业务是体外诊断、临床医疗、皮肤医美和消费者健康产品的研发、制 造、全球销售和服务。公司的主要产品是医用产品、家用产品、检验设备、检验试剂。2024年1月，普 门科技再次荣获工信部、民政部、国家卫生健康委三部委颁发的"智慧健康养老应用试点示范·示范企 业"荣誉称号；普门科技、重庆普门创的"微管内表面耐磨超疏水涂层及在医疗器械中的应用"项目获 得"2023年度'中国腐蚀与防护学会科学技术奖'一等奖"；广东省工业和信息化厅公布《2023年专精特新 中小企业名单》，全资子公司广东普门生物医疗科技有限公司荣获"专精特新中小企业"称号；普门科技 与重庆大学合作项目"全自动特定蛋白分析仪关键技术开发及产业化"荣获由中国产学研合作促进会授予 的"2023年中国产学研合作创新成果奖二等奖"。 最新一期业绩显示，2025年一季报，公司实现营业收入2.15亿元，同比-29.69%；净利润5368.47万元， 同比-49.93%，销售毛利率64.97%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13普门科技19.2216.242.6656.09亿行业平均 51.5849.144.50106 ...

来源：中国新闻网综合乐东政法、清廉海南、极目新闻等 此前，据清廉海南 2025年1月10日 消息，海南省妇女儿童医学中心检验科主任肖美芳涉嫌严 重违纪违法，接受海南省纪委监委驻省市场监督管理局纪检监察组纪律审查和乐东县监委监察 调查。 在合议庭的主持下，整个庭审有序进行，被告人肖某某在庭审过程中，对起诉书指控的犯罪事 实供认不讳，并认识到自己的错误，当庭表示认罪认罚，请求法庭从轻处罚。 合议庭认真听取 了控辩双方及被告人的意见，本案将择期宣判。 当前，各地正开展深入贯彻中央八项规定精神学习教育，旨在进一步强化党员干部的纪律意识 和规矩意识，筑牢拒腐防变的思想防线。为深化开展警示教育，达到"办理一案，教育一片"的 社会效果， 乐东县监察委员会共组织100余名党员领导干部走进法院审判庭旁听，近距离接受 廉政警示教育。 公开信息显示， 肖某某即为 肖美芳。 据海南"乐东政法"消息，近日，乐东黎族自治县人民法院公开开庭审理海南省妇女儿童医学中 心检验科原主任肖某某受贿罪一案。 公诉机关指控，2021年初至2024年期间，肖某某利用担任海南省妇女儿童医学中心检验科主 任的职务便利，为海南省某生物科技有限公司实际控制人操 ...

Core Viewpoint - The pharmaceutical industry in China is facing significant challenges in IPOs, with only five new drug companies expected to list in 2024, a sharp decline compared to previous years. The only remaining candidate on the ChiNext board is Jianfa Zhixin Medical Technology Group Co., Ltd., which has faced delays in its registration process with the CSRC for nearly 1.5 years [2][3]. Company Overview - Jianfa Zhixin primarily engages in the wholesale of medical devices, boasting substantial revenue of over 10 billion yuan. However, its profitability is concerning, with a gross margin consistently below 10% and a net profit margin nearing 1% [2][4]. - The company has not progressed to the registration stage with the CSRC, likely due to its lack of innovation and issues such as absence of patents and abnormal increases in R&D expenses [2][4]. Financial Performance - Jianfa Zhixin's revenue for the years 2020 to 2023 (first half) was 8.542 billion yuan, 10.024 billion yuan, 11.882 billion yuan, and 7.499 billion yuan, respectively, with net profits of 168 million yuan, 176 million yuan, 189 million yuan, and 103 million yuan [4][11]. - The company's gross margins for the same periods were 6.12%, 7.02%, 7.71%, and 7.72%, indicating a persistent struggle to meet the entrepreneurial board's standards [4][5]. Market Position and Competition - Jianfa Zhixin operates in a low-margin, low-value-added segment of the medical device distribution industry, which contradicts the ChiNext's focus on growth-oriented innovative enterprises [3][9]. - Compared to its peers, Jianfa Zhixin's gross margin is significantly lower, with competitors like Guoyao Holdings and Jiuzhoutong averaging gross margins above 8% [5][6]. R&D and Innovation Concerns - The company has faced scrutiny regarding its R&D expenditures, which have surged from 2.7035 million yuan in 2020 to 16.0078 million yuan in the first half of 2023, raising questions about the authenticity of these expenses [12][13]. - Jianfa Zhixin lacks patents and has only a few software copyrights, leading to doubts about its innovation capabilities. The majority of its R&D spending appears to be on outsourced projects rather than internal development [12][15]. Regulatory Challenges - The company has been questioned by regulators about its compliance with the ChiNext's innovation requirements, particularly regarding its R&D spending and the nature of its business model, which does not involve direct product development [12][16]. - Jianfa Zhixin's significant increase in R&D personnel and expenditures has raised suspicions of "last-minute" efforts to meet regulatory standards, especially given its lack of tangible innovation outputs [15][17].

标项一 标项名称:常规2包试剂及试剂辅助耗材 数量:不限 预算金额（元）: 9 0 0 0 0 0 0 单位： 批 简要规格描述或项目基本概况介绍、用途：详见采购文件 备注： 导读： 新疆维吾尔自治区传染病医院临床检验试剂及试剂辅助耗材采购项目，预算金额（元）：22550000。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 一、项目基本情况 项目编号：HCZB- 2 0 2 4 -ZB1 6 6 5（三次） 项目名称：新疆维吾尔自治区传染病医院临床检验试剂及试剂辅助耗材采购项目（三次） 采购方式：公开招标 预算金额（元）：2 2 5 5 0 0 0 0 最高限价（元）：/,/,/,/,/,/,/,/,/ 采购需求： 三、对本次采购提出询问，请按以下方式联系 1 .采购人信息 标项二 标项名称:常规免疫试剂及试剂辅助耗材 数量:不限 预算金额（元）: 4 5 0 0 0 0 0 单位： 批 简要规格描述或项目基本概况介绍、用途：详见采购文件 备注： 标项三 标项名称:分子3包试剂及试剂辅助耗材 数量:不限 预算金额（元）: 2 0 ...